Literature DB >> 8584225

Phosphorylation of tau in apolipoprotein E-deficient mice.

I Genis1, I Gordon, E Sehayek, D M Michaelson.   

Abstract

It has been suggested that the deleterious effects of the allele E4 of apolipoprotein E (apoE) in Alzheimer's disease (AD) are related to its inability to interact with the microtubule associated protein tau and to thereby prevent its hyperphosphorylation. In the present study we investigated the effects of apoE on tau phosphorylation by immunoblot analysis of the levels and extents of phosphorylation of tau of apoE-deficient mice. This revealed that mAb AT8, which is directed against a phosphorylated tau epitope, labels tau of the apoE-deficient mice more intensely than that of control mice and that the opposite occurs with mAb Tau1, which is directed against dephosphorylated tau epitopes. mAb ALZ50 also labeled the tau enriched preparations of the apoE-deficient mice more intensely than those of the controls, whereas the extents of their labeling by the phosphorylation insensitive anti-tau mAb 134 were similar. These results suggest that tau of apoE-deficient mice is hyperphosphorylated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584225     DOI: 10.1016/0304-3940(95)12007-q

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice.

Authors:  X Bi; A P Yong; J Zhou; C E Ribak; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated.

Authors:  M Tolar; M A Marques; J A Harmony; K A Crutcher
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Cerebral lipid deposition in aged apolipoprotein-E-deficient mice.

Authors:  L C Walker; C A Parker; W J Lipinski; M J Callahan; R T Carroll; S E Gandy; J D Smith; M Jucker; C L Bisgaier
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 5.  Mechanistic target of rapamycin signaling in mouse models of accelerated aging.

Authors:  Jin Young Lee; Brian K Kennedy; Chen-Yu Liao
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-01-01       Impact factor: 6.053

6.  The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice.

Authors:  Alvina W M To; Elena M Ribe; Tsu Tshen Chuang; Joern E Schroeder; Simon Lovestone
Journal:  PLoS One       Date:  2011-02-10       Impact factor: 3.240

7.  Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons.

Authors:  Hyang-Sook Hoe; Jacob Freeman; G William Rebeck
Journal:  Mol Neurodegener       Date:  2006-12-13       Impact factor: 14.195

Review 8.  Neuroantibody biomarkers: links and challenges in environmental neurodegeneration and autoimmunity.

Authors:  Hassan A N El-Fawal
Journal:  Autoimmune Dis       Date:  2014-06-23

9.  Long-term caloric restriction in ApoE-deficient mice results in neuroprotection via Fgf21-induced AMPK/mTOR pathway.

Authors:  Claire Rühlmann; Tjark Wölk; Tobias Blümel; Laura Stahn; Brigitte Vollmar; Angela Kuhla
Journal:  Aging (Albany NY)       Date:  2016-11-29       Impact factor: 5.682

10.  7,8-Dihydroxyflavone Ameliorates Cognitive Impairment by Inhibiting Expression of Tau Pathology in ApoE-Knockout Mice.

Authors:  Yang Tan; Shuke Nie; Wende Zhu; Fang Liu; Hailong Guo; Jiewen Chu; Xue B Cao; Xingjun Jiang; Yunjian Zhang; Yuzhen Li
Journal:  Front Aging Neurosci       Date:  2016-11-29       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.